Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Crocidura rapax

ABSTRACT: Crocidura rapax Genome sequencing and assembly

PROVIDER: PRJNA1101227 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29080865.fastq.gz	Fastqsanger.gz
	SRR29080866.fastq.gz	Fastqsanger.gz
	SRR29080867.fastq.gz	Fastqsanger.gz
	SRR29080868.fastq.gz	Fastqsanger.gz
	SRR29080869.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Crocidura anhuiensis

Project description:Crocidura anhuiensis Genome sequencing and assembly

| PRJNA1108462 | ENA

Crocidura shantungensis

Project description:Crocidura shantungensis mitochondrial genome

| PRJNA791823 | ENA

Crocidura indochinensis isolate:US011

Project description:Crocidura indochinensis isolate:US011 Genome sequencing and assembly

| PRJNA399360 | ENA

Crocidura russula

Project description:Crocidura russula overview

| PRJNA747551 | ENA

Crocidura shantungensis

Project description:Crocidura shantungensis overview

| PRJNA207908 | ENA

Crocidura russula

Project description:Crocidura russula in Italy

| PRJEB39879 | ENA

Crocidura sp. n. QW-2021

Project description:Crocidura sp. n. QW-2021 Genome sequencing and assembly

| PRJNA763943 | ENA

Crocidura

Project description:Ultraconserved element targeted loci from Crocidura shrews in Sulawesi, Indonesia

| PRJNA757975 | ENA

mCroZim1

Project description:Crocidura zimmermanni, genome assembly, mCroZim1

| PRJEB84167 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data